Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Isabelle J. Rao"'
Publikováno v:
The Lancet Regional Health. Americas, Vol 3, Iss , Pp 100031- (2021)
Introduction: The U.S. opioid crisis has been exacerbated by COVID-19 and the spread of synthetic opioids (e.g., fentanyl). Methods: We model the effectiveness of reduced prescribing, drug rescheduling, prescription monitoring programs (PMPs), tamper
Externí odkaz:
https://doaj.org/article/de1b7c0e0bcf4c6bb7ec173295dead40
Publikováno v:
PLoS Medicine, Vol 17, Iss 10, p e1003239 (2020)
BackgroundCycles of incarceration, drug abuse, and poverty undermine ongoing public health efforts to reduce overdose deaths and the spread of infectious disease in vulnerable populations. Jail diversion programs aim to divert low-level drug offender
Externí odkaz:
https://doaj.org/article/7c33f488f4e34023bc1a9c2ca12cfe0b
Publikováno v:
Statistics in Medicine. 41:3336-3348
Outbreaks of an endemic infectious disease can occur when the disease is introduced into a highly susceptible subpopulation or when the disease enters a network of connected individuals. For example, significant HIV outbreaks among people who inject
Autor:
Adir Shaham, Dan Yamin, Amir Yavneh, Isabelle J. Rao, Margaret L. Brandeau, Dor Kahana, Itai Ashlagi
Publikováno v:
Health Care Management Science. 23:507-519
Low adherence to prescribed medications causes substantial health and economic burden. We analyzed primary data from electronic medical records of 250,000 random patients from Israel's Maccabi Healthcare services from 2007 to 2017 to predict whether
Autor:
Isabelle J. Rao, Margaret L. Brandeau
Publikováno v:
Mathematical biosciences. 351
The problem of optimally allocating a limited supply of vaccine to control a communicable disease has broad applications in public health and has received renewed attention during the COVID-19 pandemic. This allocation problem is highly complex and n
Publikováno v:
Lancet Reg Health Am
The Lancet Regional Health. Americas, Vol 3, Iss, Pp 100031-(2021)
The Lancet Regional Health. Americas, Vol 3, Iss, Pp 100031-(2021)
Background: The opioid epidemic causes significant morbidity and mortality in the United States, and has been exacerbated by COVID-19. Methods: We extend and update a previously developed model to assess the effectiveness of the following interventio
Publikováno v:
Med Decis Making
Background The World Health Organization and US Centers for Disease Control and Prevention recommend that both infected and susceptible people wear face masks to protect against COVID-19. Methods We develop a dynamic disease model to assess the effec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::822c5c8958a0d05ed2a2c2d0efc62a4c
https://europepmc.org/articles/PMC8484026/
https://europepmc.org/articles/PMC8484026/
Publikováno v:
PLoS Medicine
PLoS Medicine, Vol 17, Iss 10, p e1003239 (2020)
PLoS Medicine, Vol 17, Iss 10, p e1003239 (2020)
Background Cycles of incarceration, drug abuse, and poverty undermine ongoing public health efforts to reduce overdose deaths and the spread of infectious disease in vulnerable populations. Jail diversion programs aim to divert low-level drug offende
Autor:
Claudia A. Algaze, Whitney Chadwick, Katsuhide Maeda, Laura Presnell, Joseph Kim, Komal Komra, Ling Loh, Andrew Y Shin, Hannah K. Bassett, Katherine M. Steffen, Monica Mafla, Alaina K. Kipps, Paul J. Sharek, Isabelle J. Rao, David Scheinker
Publikováno v:
The Journal of pediatrics. 228
To derive care targets and evaluate the impact of displaying them at the point of care on postoperative length of stay (LOS).A prospective cohort study using 2 years of historical controls within a freestanding, academic children's hospital. Patients
Optimal allocation of limited vaccine to control an infectious disease: Simple analytical conditions
Autor:
Isabelle J. Rao, Margaret L. Brandeau
Publikováno v:
Mathematical Biosciences
When allocating limited vaccines to control an infectious disease, policy makers frequently have goals relating to individual health benefits (e.g., reduced morbidity and mortality) as well as population-level health benefits (e.g., reduced transmiss